VFA
LFCR icon

Valeo Financial Advisors’s Lifecore Biomedical LFCR Stock Holding History

Valeo Financial Advisors’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,000
Closed -$20K – 2094
2020
Q1 		$20K Hold
2,000
– – ﹤0.01% 899
2019
Q4 		$23K Hold
2,000
– – ﹤0.01% 890
2019
Q3 		$22K Hold
2,000
– – ﹤0.01% 826
2019
Q2 		$19K Buy
+2,000
New +$20.2K ﹤0.01% 864

Other funds holding LFCR

Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Valeo Financial Advisors's LFCR Position: Q2 2020 in Review

Valeo Financial Advisors sold out of Lifecore Biomedical (LFCR) in Q2 2020, closing a stake of 2,000 shares — an estimated $20K sold.

Valeo Financial Advisors first reported a position in LFCR in Q2 2019 and held it in 4 quarters. The position peaked at $23K in Q4 2019. 95 funds tracked by Wall St. Rank hold LFCR as of Q2 2020.

  • Valeo Financial Advisors reported no remaining Lifecore Biomedical position as of Q2 2020 after selling out during the quarter.
  • Valeo Financial Advisors sold 2,000 Lifecore Biomedical shares in Q2 2020, an estimated $20K.
  • Valeo Financial Advisors first reported a position in Lifecore Biomedical in Q2 2019 and held it in 4 quarters.
  • Valeo Financial Advisors's Lifecore Biomedical position peaked at $23K in Q4 2019.
  • 95 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2020.

Based on Valeo Financial Advisors's 13F filing for Q2 2020, filed 20 Jul 2020.